SRL
ASND icon

Scientech Research LLC’s Ascendis Pharma A/S ASND Stock Holding History

Scientech Research LLC’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,017
Closed -$430K – 474
2025
Q4 		$430K Buy
+2,017
New +$417K 0.27% 110
2024
Q4 		– Sell
-5,196
Closed -$776K – 577
2024
Q3 		$776K Buy
+5,196
New +$702K 0.15% 263
2024
Q1 		– Sell
-3,217
Closed -$405K – 412
2023
Q4 		$405K Buy
+3,217
New +$321K 0.4% 61

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Scientech Research LLC's ASND Position: Q1 2026 in Review

Scientech Research LLC sold out of Ascendis Pharma A/S (ASND) in Q1 2026, closing a stake of 2,017 shares — an estimated $430K sold.

Scientech Research LLC first reported a position in ASND in Q4 2023 and held it in 3 quarters. The position peaked at $776K in Q3 2024. 274 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

  • Scientech Research LLC reported no remaining Ascendis Pharma A/S position as of Q1 2026 after selling out during the quarter.
  • Scientech Research LLC sold 2,017 Ascendis Pharma A/S shares in Q1 2026, an estimated $430K.
  • Scientech Research LLC first reported a position in Ascendis Pharma A/S in Q4 2023 and held it in 3 quarters.
  • Scientech Research LLC's Ascendis Pharma A/S position peaked at $776K in Q3 2024.
  • 274 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on Scientech Research LLC's 13F filing for Q1 2026, filed 15 May 2026.